Z. Zumsteg, D. Spratt, P. I. Zhang, Z. Yamada, Y. Kollmeier et al., A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy, European Urology, vol.64, issue.6, pp.895-902, 2013.
DOI : 10.1016/j.eururo.2013.03.033

J. Locke, D. Pra, A. Supiot, S. Warde, P. Bristow et al., Synergistic action of image-guided radiotherapy and androgen deprivation therapy, Nature Reviews Urology, vol.34, issue.4, pp.193-204, 2015.
DOI : 10.1001/jama.280.11.969

R. Vergis, C. Corbishley, A. Norman, J. Bartlett, S. Jhavar et al., Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study, The Lancet Oncology, vol.9, issue.4, pp.342-51, 2008.
DOI : 10.1016/S1470-2045(08)70076-7

E. Lalonde, A. Ishkanian, J. Sykes, M. Fraser, H. Ross-adams et al., Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study, The Lancet Oncology, vol.15, issue.13, pp.1521-1553, 2014.
DOI : 10.1016/S1470-2045(14)71021-6

A. Turaka, M. Buyyounouski, A. Hanlon, E. Horwitz, R. Greenberg et al., Hypoxic Prostate/Muscle Po2 Ratio Predicts for Outcome in Patients With Localized Prostate Cancer: Long-Term Results, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.3, pp.433-442, 2012.
DOI : 10.1016/j.ijrobp.2011.05.037

M. Milosevic, W. P. Menard, C. Chung, P. Toi, A. Ishkanian et al., Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer, Clinical Cancer Research, vol.18, issue.7, pp.2108-141078, 2012.
DOI : 10.1158/1078-0432.CCR-11-2711

URL : http://clincancerres.aacrjournals.org/content/clincanres/18/7/2108.full.pdf

C. Ling, J. Humm, S. Larson, H. Amols, Z. Fuks et al., Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality, International Journal of Radiation Oncology*Biology*Physics, vol.47, issue.3, pp.551-60, 2000.
DOI : 10.1016/S0360-3016(00)00467-3

S. Supiot, A. Lisbona, F. Paris, D. Azria, and P. Fenoglietto, ????Dose-painting??????: mythe ou r??alit?????, Cancer/Radioth??rapie, vol.14, issue.6-7, pp.554-62, 2010.
DOI : 10.1016/j.canrad.2010.06.005

D. Pra, A. Locke, J. Borst, G. Supiot, S. Bristow et al., Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer, Front Oncol, vol.6, p.24, 2016.

M. Horsman, L. Mortensen, J. Petersen, M. Busk, and J. Overgaard, Imaging hypoxia to improve radiotherapy outcome, Nature Reviews Clinical Oncology, vol.42, issue.12, pp.674-87, 2012.
DOI : 10.1007/s00259-007-0522-2

J. Rasey, W. Koh, M. Evans, L. Peterson, T. Lewellen et al., Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients, International Journal of Radiation Oncology*Biology*Physics, vol.36, issue.2, pp.417-445, 1996.
DOI : 10.1016/S0360-3016(96)00325-2

M. Milosevic, P. Chung, C. Parker, R. Bristow, A. Toi et al., Androgen Withdrawal in Patients Reduces Prostate Cancer Hypoxia: Implications for Disease Progression and Radiation Response, Cancer Research, vol.67, issue.13, pp.6022-50008, 1158.
DOI : 10.1158/0008-5472.CAN-07-0561

URL : http://cancerres.aacrjournals.org/content/canres/67/13/6022.full.pdf

D. Thorwarth, M. Notohamiprodjo, D. Zips, and A. Muller, Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: A feasibility study, Zeitschrift f??r Medizinische Physik, vol.27, issue.1, pp.21-30, 2017.
DOI : 10.1016/j.zemedi.2016.02.002

R. Garcia-parra, D. Wood, R. Shah, J. Siddiqui, H. Hussain et al., Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques, European Journal of Nuclear Medicine and Molecular Imaging, vol.71, issue.10, pp.1816-1839, 2011.
DOI : 10.1016/j.ijrobp.2007.06.079

URL : http://europepmc.org/articles/pmc3259612?pdf=render

N. Rupp, P. Schuffler, Q. Zhong, F. Falkner, M. Rechsteiner et al., Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer, J Pathol Inform, vol.7, issue.3, pp.2153-3539, 2016.

R. Airley, A. Evans, A. Mobasheri, and S. Hewitt, Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays, Annals of Anatomy - Anatomischer Anzeiger, vol.192, issue.3, pp.133-141, 2010.
DOI : 10.1016/j.aanat.2010.03.001

URL : http://researchonline.ljmu.ac.uk/2334/3/Glut-1%20TARP%202009.pdf

K. Reinicke, P. Sotomayor, P. Cisterna, C. Delgado, F. Nualart et al., Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue, Journal of Cellular Biochemistry, vol.56, issue.2, pp.553-62, 2012.
DOI : 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7

S. Chopra, W. Foltz, M. Milosevic, A. Toi, R. Bristow et al., Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: A pilot study in men with prostate cancer, International Journal of Radiation Biology, vol.39, issue.9, pp.805-818, 2009.
DOI : 10.1016/S0360-3016(97)00328-3

K. Carvalho, I. Cunha, R. Rocha, F. Ayala, M. Cajaiba et al., GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker, Clinics, vol.66, issue.6, pp.965-72, 2011.
DOI : 10.1590/S1807-59322011000600008

URL : http://www.scielo.br/pdf/clin/v66n6/08.pdf

D. Carnell, R. Smith, F. Daley, M. Saunders, S. Bentzen et al., An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.1, pp.91-100, 2006.
DOI : 10.1016/j.ijrobp.2005.11.044

P. Hoskin, D. Carnell, N. Taylor, R. Smith, J. Stirling et al., Hypoxia in Prostate Cancer: Correlation of BOLD-MRI With Pimonidazole Immunohistochemistry???Initial Observations, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.4, pp.1065-71, 2007.
DOI : 10.1016/j.ijrobp.2007.01.018

G. Ghobadi, J. De-jong, B. Hollmann, B. Van-triest, H. Van-der-poel et al., Histopathology-derived modeling of prostate cancer tumor control probability: Implications for the dose to the tumor and the gland, Radiotherapy and Oncology, vol.119, issue.1, pp.97-103, 2016.
DOI : 10.1016/j.radonc.2016.02.015

R. Bundschuh, C. Wendl, G. Weirich, M. Eiber, M. Souvatzoglou et al., Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens, European Journal of Nuclear Medicine and Molecular Imaging, vol.62, issue.6, pp.824-855, 2013.
DOI : 10.1016/j.ijrobp.2004.12.089

C. Parker, M. Milosevic, T. A. Sweet, J. Panzarella, T. Bristow et al., Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer, International Journal of Radiation Oncology*Biology*Physics, vol.58, issue.3, pp.750-757, 2004.
DOI : 10.1016/S0360-3016(03)01621-3

D. Taiakina, D. Pra, A. Bristow, and R. , Intratumoral Hypoxia as the Genesis of Genetic Instability and Clinical Prognosis in Prostate Cancer, Adv Exp Med Biol, vol.772, pp.189-204978, 2014.
DOI : 10.1007/978-1-4614-5915-6_9

S. Chopra, A. Toi, N. Taback, A. Evans, M. Haider et al., Pathological Predictors for Site of Local Recurrence After Radiotherapy for Prostate Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.3
DOI : 10.1016/j.ijrobp.2011.05.035

, Int J Radiat Oncol Biol Phys, vol.82, pp.441-449, 2012.

G. Bauman, M. Haider, U. Van-der-heide, and C. Menard, Boosting imaging defined dominant prostatic tumors: A systematic review, Radiotherapy and Oncology, vol.107, issue.3, pp.274-81, 2013.
DOI : 10.1016/j.radonc.2013.04.027

V. Potiron, R. Abderrahmani, E. Giang, S. Chiavassa, D. Tomaso et al., Radiosensitization of prostate cancer cells by the dual PI3K

, Radiother Oncol, vol.106, pp.138-184, 2013.

M. Roach, G. Hanks, H. Thames, . Jr, P. Schellhammer et al., Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.4, pp.965-74, 2006.
DOI : 10.1016/j.ijrobp.2006.04.029

K. Pinker, P. Andrzejewski, P. Baltzer, S. Polanec, A. Sturdza et al., Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study, PLOS ONE, vol.30, issue.9, p.155333, 2016.
DOI : 10.1371/journal.pone.0155333.s002

D. Zips, K. Zophel, N. Abolmaali, R. Perrin, A. Abramyuk et al., Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer, Radiotherapy and Oncology, vol.105, issue.1, pp.21-29, 2012.
DOI : 10.1016/j.radonc.2012.08.019

T. Shepherd, M. Teras, R. Beichel, R. Boellaard, M. Bruynooghe et al., Comparative Study With New Accuracy Metrics for Target Volume Contouring in PET Image Guided Radiation Therapy, IEEE Transactions on Medical Imaging, vol.31, issue.11, pp.2006-2030, 2012.
DOI : 10.1109/TMI.2012.2202322

URL : https://hal.archives-ouvertes.fr/hal-00763488

J. Weinreb, J. Barentsz, P. Choyke, F. Cornud, M. Haider et al., PI-RADS Prostate Imaging ??? Reporting and Data System: 2015, Version 2, European Urology, vol.69, issue.1, pp.16-40, 2016.
DOI : 10.1016/j.eururo.2015.08.052

M. Anwar, A. Westphalen, A. Jung, S. Noworolski, J. Simko et al., Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: Quantitative analysis of imaging contour compared to whole-mount histopathology, Radiotherapy and Oncology, vol.110, issue.2, pp.303-311, 2014.
DOI : 10.1016/j.radonc.2013.12.003

M. Hatt, C. Le-rest, C. Turzo, A. Roux, C. Visvikis et al., A Fuzzy Locally Adaptive Bayesian Segmentation Approach for Volume Determination in PET, IEEE Transactions on Medical Imaging, vol.28, issue.6, pp.881-93, 2008.
DOI : 10.1109/TMI.2008.2012036

URL : https://hal.archives-ouvertes.fr/inserm-00372910

M. Hatt, C. Le-rest, C. Descourt, P. Dekker, A. et al.,

, Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications, Int J Radiat Oncol Biol Phys, vol.77, pp.301-309, 2010.